Recorded Chinese product: 注射用香菇多糖注射用香菇多糖
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 山西振东泰盛制药有限公司Chinese legal name: 山西振东泰盛制药有限公司
主要成分Active Ingredients
- 香菇多糖Xianggu Duotang
药物知识说明
香菇多糖是一种在国家药监局注册认定的药品。该药品含有香菇多糖-9eda009c等成分。
该药品关联的活性成分包括：香菇多糖Xianggu Duotang。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：山西振东泰盛制药有限公司Chinese legal name: 山西振东泰盛制药有限公司。
您可以探索含有相同成分的其他药品：香菇多糖-9eda009c成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 注射用香菇多糖) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 香菇多糖Xianggu Duotang.
Manufacturers recorded for this product: 山西振东泰盛制药有限公司Chinese legal name: 山西振东泰盛制药有限公司.
Explore other medicines containing the same ingredient: 香菇多糖 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 注射用香菇多糖Recorded Chinese product: 注射用香菇多糖
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 1mg1 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 山西振东泰盛制药有限公司Chinese legal name: 山西振东泰盛制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20064611
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20064611
Manufacturer
Chinese legal name: 山西振东泰盛制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20064611
生产企业
山西振东泰盛制药有限公司(国产)
适应症
用于恶性肿瘤的辅助治疗。
用法用量
1.一次1瓶(1mg)，一周两次或遵医嘱。|2.用2ml注射用水振摇溶解，加入250ml生理盐水或5%葡萄糖注射液中静脉滴注，或用5%葡萄糖注射液5-10ml完全溶解后静脉注射
不良反应
1.休克：较为罕见，因此在病人用药后应密切观察。出现口内异常感、畏寒、心律异常、血压下降、呼吸困难等症状时应立即停药并适当及时处理。 |2.皮肤：偶见皮疹、发红，应及时停药，必要进行处理。 |3.呼吸系统：偶见胸部压迫感、咽 喉狭窄感，应密切观察。发生时应减慢给药速度，如改静脉推注为滴注或减慢滴注速度。 |4.消化系统：偶见恶心、呕吐、食欲不振。 |5.神经系统：偶见头痛，头重、头晕。 |6.血液：偶见红、白细胞及血红蛋白减少。 |7.其它：偶见发热，出汗、面部潮红等症状。
禁忌
对本品过敏患者禁用。
注意事项
1.虽然临床试验仅有很少数病人发生头晕、胸闷、面部潮 红等一过性反应，临床仍应注意过敏反应的可能性。 |2.对于本人或家族中容易发生支气管哮喘、荨麻疹等过敏症状的特异性体质患者应慎用。 |3.本品加入溶剂后要用力振摇使完全溶解即刻使用。 |4.本品应根据医生处方和遵照医嘱使用。
贮藏
密闭保存。
规格
1mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.